Omega-3 Fatty Acids strong

Fish Oil vs. Krill Oil vs. Algae Oil: Which Omega-3 Source Is Best?

Fish Oil vs. Krill Oil vs. Algae Oil: Which Omega-3 Source Is Best?
TL;DR
Fish oil provides the highest EPA/DHA per capsule and has the largest evidence base (thousands of studies). Krill oil delivers omega-3s in phospholipid form with potentially better absorption per milligram, plus astaxanthin, but at lower total EPA/DHA doses per capsule and higher cost. Algae oil is the only vegan DHA source and the most sustainable option — equivalent efficacy to fish oil for raising blood DHA levels. For most people, high-quality fish oil is the most cost-effective choice. Choose krill if you want the phospholipid advantage at a premium. Choose algae if you are plant-based or prioritize sustainability.
ELI5
Fish oil, krill oil, and algae oil all give you omega-3 fats that are good for your brain, heart, and joints. Fish oil has the most omega-3 per pill and is the cheapest. Krill oil might be absorbed a little better because of its special form, but you get less per pill and pay more. Algae oil is made from tiny sea plants and is the best choice if you do not eat animal products. All three work — the best one is the one you will actually take.

At a Glance

PropertyValue
Evidence LevelStrong (fish oil: thousands of RCTs; krill/algae: moderate, smaller evidence base)
Primary UseCardiovascular risk reduction, anti-inflammation, brain health, triglyceride lowering
Key DifferenceDelivery form (triglyceride vs. phospholipid), EPA/DHA ratio, sustainability, cost

Fish Oil vs. Krill Oil vs. Algae Oil: An Honest Comparison

The omega-3 supplement market generates over $4 billion annually, and the marketing claims can make it nearly impossible to make a rational choice. Krill oil brands claim superior absorption. Fish oil brands point to massive clinical evidence. Algae oil brands argue sustainability and purity.

Here is what the evidence actually says about each, stripped of marketing.

The Three Sources Compared

Fish Oil

Fish oil is extracted from cold-water fatty fish — primarily anchovies, sardines, mackerel, and herring. The omega-3 fatty acids (EPA and DHA) are delivered in triglyceride or ethyl ester form.

Strengths:

  • Highest EPA/DHA content per capsule (500-1,000 mg in a standard soft gel)
  • Largest clinical evidence base in all of supplement medicine (>4,000 clinical trials)
  • Most affordable omega-3 source per gram of EPA/DHA
  • Available in concentrated forms (>90% omega-3 content) for high-dose applications

Weaknesses:

  • Quality varies enormously between brands (oxidation, contaminant levels, actual EPA/DHA content)
  • Fishy aftertaste and burps in lower-quality products
  • Environmental concerns about overfishing (mitigated by Friend of the Sea and MSC certifications)
  • Potential heavy metal contamination (mercury, PCBs) if not molecularly distilled

Krill Oil

Krill oil is extracted from Antarctic krill (Euphausia superba), small crustaceans at the base of the marine food chain. The omega-3s are delivered primarily in phospholipid form, with the antioxidant astaxanthin naturally present.

Strengths:

  • Phospholipid delivery: cell membranes are made of phospholipids, so phospholipid-bound omega-3s may integrate more efficiently. Ulven et al. demonstrated equivalent biomarker improvements with krill oil at lower total EPA/DHA doses compared to fish oil (1).
  • Astaxanthin: a potent antioxidant that protects the omega-3s from oxidation and provides independent anti-inflammatory benefits.
  • Lower on the food chain: less accumulation of heavy metals and persistent organic pollutants.
  • No fishy aftertaste (the phospholipid form mixes with gastric contents differently).

Weaknesses:

  • Lower EPA/DHA per capsule (typically 100-300 mg combined EPA/DHA per soft gel)
  • Significantly more expensive per gram of EPA/DHA (3-5x fish oil)
  • Smaller clinical evidence base — the major cardiovascular and longevity trials were conducted with fish oil, not krill oil
  • Shellfish allergen risk

Algae Oil

Algae oil is produced from microalgae (Schizochytrium or Crypthecodinium species) cultivated in controlled environments. These are the organisms that actually produce DHA — fish accumulate it by eating algae. Algae oil goes directly to the source.

Strengths:

  • Vegan/vegetarian compatible — the only plant-based DHA source
  • Environmentally sustainable (no ocean harvesting, no bycatch)
  • Free from ocean-borne contaminants (produced in controlled bioreactors)
  • Equivalent efficacy for raising blood DHA levels (2)

Weaknesses:

  • Typically DHA-dominant with lower EPA content (some newer products address this)
  • More expensive than fish oil (1.5-3x per gram of DHA)
  • Smaller clinical evidence base than fish oil
  • Some products have off-flavors

Head-to-Head Data

ParameterFish OilKrill OilAlgae Oil
EPA per capsule300-500 mg60-120 mg100-200 mg
DHA per capsule200-400 mg40-80 mg200-400 mg
Delivery formTriglyceride or ethyl esterPhospholipidTriglyceride
BioavailabilityGood (TG form > EE form)Potentially superior per mgGood
AstaxanthinNoYes (natural)No
Heavy metal riskLow (molecular distillation)Very low (food chain base)Negligible (bioreactor)
Environmental impactModerate (certifications help)Low-moderateLowest
Cost per 1g EPA+DHA$0.10-0.30$0.50-1.50$0.25-0.60
VeganNoNoYes
Clinical trial evidence4,000+ trials~50 trials~100 trials
Fishy burpsCommon (low quality)RareRare

The Phospholipid Question

The most important scientific debate in this comparison is whether phospholipid-bound omega-3s (krill oil) are meaningfully better absorbed than triglyceride-bound omega-3s (fish oil).

The theoretical advantage: Cell membranes are phospholipid bilayers. Phospholipid-bound EPA/DHA may integrate into membranes more efficiently than triglyceride-bound forms, which must first be hydrolyzed by pancreatic lipase and reassembled.

What the studies show: Ulven et al. found that 543 mg EPA/DHA from krill oil produced the same increase in plasma omega-3 levels as 864 mg EPA/DHA from fish oil — suggesting approximately 60% better bioavailability per milligram (1). However, other studies have found smaller differences, and the clinical significance (vs. simply taking a higher dose of fish oil) remains debated.

My position: The phospholipid advantage is real but modest. It does not justify a 3-5x price premium for most people. If you are willing to take two fish oil capsules instead of one, you will achieve the same or higher blood levels at lower cost. The exception: if you have fat malabsorption issues (pancreatic insufficiency, bile acid deficiency), phospholipid-bound omega-3s may genuinely absorb better.

Who Should Choose What

Choose Fish Oil If:

  • You want the most evidence-backed option
  • Cost-effectiveness matters
  • You need high-dose omega-3 (>2g/day for triglycerides or inflammation)
  • You have no quality concerns with a reputable brand

Recommended products: Look for IFOS (International Fish Oil Standards) 5-star certification, triglyceride form (not ethyl ester), and at least 500 mg combined EPA/DHA per capsule. Molecularly distilled for contaminant removal.

Choose Krill Oil If:

  • You cannot tolerate fish oil (fishy burps, GI effects)
  • You value the additional astaxanthin antioxidant
  • You want phospholipid delivery and do not mind the premium
  • You need only moderate doses (500-1,000 mg EPA/DHA/day)

Choose Algae Oil If:

  • You are vegetarian, vegan, or plant-based
  • Environmental sustainability is a priority
  • You are allergic to fish or shellfish
  • You want the purest source (no ocean contaminant risk)
  • You primarily need DHA (brain health, pregnancy)

Dosing Guidelines (Regardless of Source)

For detailed inflammation-specific dosing, see my omega-3 dosage for inflammation guide.

GoalEPA/DHA TargetNotes
General health maintenance250-500 mg combinedMinimum for cardiovascular benefit
Cardiovascular risk reduction1,000-2,000 mg combinedREDUCE-IT trial used 4g EPA
Triglyceride reduction2,000-4,000 mg combinedPrescription-level doses; monitor with physician
Anti-inflammation2,000-3,000 mg combinedHigher EPA ratios preferred
Brain health / DHA focus1,000-2,000 mg DHAAlgae oil often best for DHA-dominant goals
Pregnancy200-300 mg DHA minimumWHO recommendation; algae safe for pregnancy

Quality Red Flags

Regardless of which source you choose, watch for these quality issues:

Fish oil red flags:

  • Ethyl ester form (lower absorption than triglyceride)
  • No third-party testing certification (IFOS, NSF, USP)
  • Low EPA/DHA per capsule (<500 mg combined in “1,000 mg fish oil”)
  • Rancid smell when capsules are cut open

Krill oil red flags:

  • Unrealistic EPA/DHA claims (krill oil naturally has lower concentrations)
  • No astaxanthin listed (may be an inferior extract)
  • No sustainable harvesting certification (MSC or CCAMLR)

Algae oil red flags:

  • Only DHA, no EPA (some conditions require both)
  • Very low DHA per capsule (<200 mg)
  • No third-party testing for oxidation values

The Bottom Line

All three omega-3 sources work. The clinical evidence for cardiovascular, neurological, and anti-inflammatory benefits comes overwhelmingly from fish oil, but the omega-3 molecules themselves are identical regardless of source. Fish oil is the most cost-effective and evidence-supported option for most people. Krill oil offers modest absorption advantages at a significant price premium. Algae oil is the clear choice for plant-based diets and environmental sustainability. What I tell my patients: the best omega-3 supplement is the one you will take consistently, in adequate doses, from a quality-tested brand.

References

  1. Ulven SM, Kirkhus B, Lamglait A, et al. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids. 2011;46(1):37-46. doi:10.1007/s11745-010-3490-4

  2. Ryan L, Symington AM. Algal-oil supplements are a viable alternative to fish-oil supplements in terms of docosahexaenoic acid (22:6n-3; DHA). Journal of Functional Foods. 2015;19:852-858. doi:10.1016/j.jff.2014.06.023

  3. Maki KC, Palacios OM, Bell M, Toth PP. Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: an updated meta-analysis and review of research gaps. Journal of Clinical Lipidology. 2017;11(5):1152-1160. doi:10.1016/j.jacl.2017.07.010